In sweet-toothed Britain, sugary soda levy may have limited impact With its surprise move to tax sugary drinks, Britain joins several Western countries battling a key suspect in rising rates of obesity and diabetes, but health and industry experts say the levy is limited and its effect may be small.1
Cholesterol pill boosts cancer immunotherapy, at least in mice Tweaking cholesterol levels with a simple pill may boost the effectiveness of new immunotherapy drugs that are starting to revolutionize the treatment of cancers, experiments in mice suggest.
Parents seek postcards for 3-year-old with terminal cancer Ellie Walton, 3, has been fighting a rare brain tumor since she was four months old.
John Grisham book turns spotlight on futuristic cancer treatment A new book by bestselling author John Grisham is giving new impetus to a handful of companies striving to develop what they say could be a trailblazing treatment for cancer and Alzheimer's disease.
Financial burden of cancer can harm quality of life Almost a third of U.S. cancer survivors face financial burdens, and physical and metal health tends to be worse for those who do, according to a new study.
22-year-old dies of rare cancer after doctors mistook disease for pregnancy Family and friends of a 22-year-old British woman are grieving her death after doctors mistook a rare form of cancer as pregnancy.
FDA expands use of Pfizer drug for rare form of lung cancer WASHINGTON (AP) -- The Food and Drug Administration expanded approval of a Pfizer drug to treat a small subset of lung cancer patients with a rare mutation.
Animal study links Splenda to cancer Sure, the idea of getting your sugar fix without the calories always seems enticing, but new research suggests that Splenda—an artificial sweetener recently considered safe—may contribute to serious health problems like cancer.
